At a glance
- Originator Wyeth
- Class Antihyperglycaemics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 13 May 2003 No development reported - Preclinical for Diabetes mellitus in USA (unspecified route)
- 27 Mar 2002 American Home Products and its subsidiaries Wyeth-Ayerst and Wyeth Lederle are both now called Wyeth
- 18 May 2001 Preclinical development for Diabetes mellitus in USA (Unknown route)